Osteopathic Sympathetic Harmonization and Depression
Assessment of Effectiveness of the Osteopathic Sympathetic Harmonization Applications on the Sympathetic Nervous System and the HPA Axis With Depression Diagnosed Adolescents: A Double-blind, Placebo-controlled, Randomized Study
1 other identifier
interventional
39
1 country
1
Brief Summary
Depression appears to be resistant to the available pharmacological treatments. Autonomic responses accompanied by any psychological stress are sympathetic nervous system (SNS) and neuroendocrine responses are formed by hypothalamus-pituitary-adrenal (HPA) axis. The purpose of this study is; assessment of effectiveness of osteopathic approach on sympathetic nervous system and HPA axis in adolescents with depression.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2017
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 11, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 23, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
June 5, 2018
CompletedFirst Submitted
Initial submission to the registry
April 4, 2021
CompletedFirst Posted
Study publicly available on registry
April 9, 2021
CompletedApril 9, 2021
April 1, 2021
5 months
April 4, 2021
April 7, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (8)
The Beck Depression Inventory (BDI)
The Beck Depression Inventory (BDI) is a 21-item, self-report rating inventory that measures characteristic attitudes and symptoms of depression.
Before intervention
The State-Trait Anxiety Inventory (STAI) Form - 1
The State-Trait Anxiety Inventory (STAI) is a commonly used measure of trait and state anxiety. It can be used in clinical settings to diagnose anxiety and to distinguish it from depressive syndromes. It also is often used in research as an indicator of caregiver distress.
Before intervention
Change from Baseline The State-Trait Anxiety Inventory (STAI) Form - 2 at 20 minutes
The State-Trait Anxiety Inventory (STAI) is a commonly used measure of trait and state anxiety. It can be used in clinical settings to diagnose anxiety and to distinguish it from depressive syndromes. It also is often used in research as an indicator of caregiver distress.
Before intervention, immediately after the intervention, 20 minutes after the intervention
Change from Baseline Heart rate and blood pressure measurements at 20 minutes
Heart rate (beats per minute) and blood pressure (mm/Hg) were measured with automatic blood pressure monitor (the Microlife BP 3BT0-A). It is a clinically validated and 1-star automatic blood pressure monitor
Before intervention, immediately after the intervention, 20 minutes after the intervention
Change from Baseline Salivary Biomarkers at 20 minutes
Salivary a-amylase and cortisol levels were measured for each sample. These biomarkers were analysed Enzyme-Linked Immunosorbent Assay.
Before intervention, immediately after the intervention, 20 second after the intervention
Demographic data
Sex; male or female
Before intervention
Demographic data
Age; years
Before intervention
Demographic data
Height (m); weight (kg); body mass index (kg/m2)
Before intervention
Study Arms (2)
Osteopathy Group
EXPERIMENTALStimulation on the sympathetic truncus and prevertebral ganglia
Control Group
SHAM COMPARATORStimulation on similar areas with lighter touch and shorter duration
Interventions
Treatments that harmonize at the sympathetic nerves or plexus, e.g., sympathetic trunk stimulation by means of the rib-raise technique or stimulation of the prevertebral ganglia.
Different location, size and time of the rib-raise technique or stimulation of the prevertebral ganglia.
Eligibility Criteria
You may qualify if:
- To be diagnosed with clinical depression by a psychiatrist according to The Diagnostic and Statistical Manual of Mental Disorders (DSM-5) criteria
- Volunteering to participate in the study
You may not qualify if:
- Fever over 38.5
- Acute injury or infection
- Rib fracture
- Cardiac arrhythmia
- Using drugs that affect cortisol levels (oral contraceptives, hormonal drugs, antidepressants, antipsychotics etc.)
- Being pregnant, premenstrual or in the menstrual period for female participants
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sivas Cumhuriyet University
Sivas, 58140, Turkey (Türkiye)
Related Publications (2)
Henderson AT, Fisher JF, Blair J, Shea C, Li TS, Bridges KG. Effects of rib raising on the autonomic nervous system: a pilot study using noninvasive biomarkers. J Am Osteopath Assoc. 2010 Jun;110(6):324-30.
PMID: 20606239BACKGROUNDPala OO, Citaker S, Guney E, Sepici A, Guveli GM, Arslan B, Guru M. Effectiveness of osteopathic manipulative applications on hypothalamic-pituitary-adrenal (HPA) axis in youth with major depressive disorder: a randomized double-blind, placebo-controlled trial. J Osteopath Med. 2024 Feb 29;124(6):267-275. doi: 10.1515/jom-2023-0056. eCollection 2024 Jun 1.
PMID: 38414339DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Omer Osman PALA, PhD
Cumhuriyet University, Faculty of Health Sciences, Physiotherapy and Rehabilitation
- PRINCIPAL INVESTIGATOR
Seyit CITAKER, Prof
Gazi University, Faculty of Health Sciences, Physiotherapy and Rehabilitation
- PRINCIPAL INVESTIGATOR
Esra GUNEY, Assoc. Prof
Gazi University, Faculty of Medicine, Child and Adolescent Psychiatry
- PRINCIPAL INVESTIGATOR
Aylin SEPICI DINCEL, Prof
Gazi University, Faculty of Medicine, Medical Biochemistry
- PRINCIPAL INVESTIGATOR
Güner Melike GUVELI, MD
Gazi University, Faculty of Medicine, Child and Adolescent Psychiatry
- PRINCIPAL INVESTIGATOR
Burak ARSLAN, MD
Gazi University, Faculty of Medicine, Medical Biochemistry
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Double-blind trial
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
April 4, 2021
First Posted
April 9, 2021
Study Start
October 11, 2017
Primary Completion
March 23, 2018
Study Completion
June 5, 2018
Last Updated
April 9, 2021
Record last verified: 2021-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- CSR, ANALYTIC CODE
- Time Frame
- January 1, 2022